CIBC World Market
DFTX

CIBC World Market’s Definium Therapeutics DFTX Stock Holding History

CIBC World Market’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190K Buy
+10,049
New +$171K ﹤0.01% 1404
2022
Q3 		– Sell
-1,215
Closed -$11.7K – 1291
2022
Q2 		$12K Buy
1,215
+1
+0.1% +$13 ﹤0.01% 1251
2022
Q1 		$20K Buy
1,214
+178
+17% +$3.09K ﹤0.01% 1285
2021
Q4 		$21K Buy
1,036
+11
+1% +$351 ﹤0.01% 1309
2021
Q3 		$36K Buy
+1,025
New +$44.3K ﹤0.01% 1313

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIBC World Market's DFTX Position: Q1 2026 in Review

CIBC World Market opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 10,049 shares worth $190K. The stake represents ﹤0.01% of the portfolio and ranks #1404 among its holdings. This is a return to the name: CIBC World Market previously reported a position in DFTX as recently as Q2 2022.

CIBC World Market first reported a position in DFTX in Q3 2021 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • CIBC World Market held 10,049 shares of Definium Therapeutics worth $190K as of Q1 2026.
  • Definium Therapeutics was a new CIBC World Market position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #1404 holding.
  • CIBC World Market first reported a position in Definium Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.